Aceso Advances Complementary Peptide Approaches to Enhance CFTR Function
Vienna, Austria – September 6–11, 2026 — Aceso Therapeutics is presenting new research at the 38th European Peptide Symposium, highlighting promising advances in peptide-based approaches to address key challenges in cystic fibrosis (CF). Prisca Boisguerin, PhD, CTO and co-founder of Aceso Therapeutics, is presenting research focused on the development of innovative peptides designed to improve […]